Document ID: chunk:federal_register_of_legislation:F2024C00214:reg:9:p2
Version: federal_register_of_legislation:F2024C00214
Segment Type: reg
Provision Reference: reg 9 (pt 2/4)
Character Range: 7850–10955

having infection with hepatitis C virus at the time of the clinical onset of non-Hodgkin lymphoma;
(14)      having infection with hepatitis B virus at the time of the clinical onset of non-Hodgkin lymphoma;
(15)      for Burkitt lymphoma only, having infection with Plasmodium falciparum at the time of the clinical onset of non-Hodgkin lymphoma;
(16)      having Hodgkin's lymphoma before the clinical onset of non-Hodgkin lymphoma;
(17)      inhaling, ingesting or having cutaneous contact with a phenoxy acid herbicide from the specified list:
(a)          for a cumulative period of at least 1 000 hours, within a consecutive period of ten years, before the clinical onset of non‑Hodgkin lymphoma; and
(b)          where the first exposure occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: phenoxy acid herbicide from the specified list is defined in the Schedule 1 – Dictionary.
(18)      being:
(a)          on land in Vietnam; or
(b)          at sea in Vietnamese waters; or
(c)          on board a vessel and consuming potable water supplied on that vessel, when the water supply had been produced by evaporative distillation of estuarine Vietnamese waters,
         for a cumulative period of at least 30 days, at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: being: (a) on land in Vietnam; or (b) at sea in Vietnamese waters, estuarine Vietnamese waters and potable water are defined in the Schedule 1 – Dictionary.
(19)      inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
            (a)          for a cumulative period of at least 1 000 hours, within a consecutive period of ten years, before the clinical onset of non‑Hodgkin lymphoma; and
            (b)          where the first exposure occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 – Dictionary.
(20)      being exposed to benzene as specified:
            (a)          for a cumulative total of at least 2 500 hours within a continuous period of five years before the clinical onset of non-Hodgkin lymphoma; and
            (b)          where the first exposure in that period occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: being exposed to benzene as specified is defined in the Schedule 1 – Dictionary.
(21)      receiving greater than ten ppm-years of cumulative exposure to benzene before the clinical onset of non-Hodgkin lymphoma, and where the first exposure occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: ppm-years is defined in the Schedule 1 – Dictionary.
(22)      inhaling ethylene oxide vapour:
            (a)          for a cumulative total of at least 2 500 hours within a consecutive period of ten years before the clinical onset